Ignite Creation Date:
2025-12-24 @ 10:24 PM
Ignite Modification Date:
2026-01-24 @ 5:28 PM
Study NCT ID:
NCT02671435
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-07-22
First Post:
2016-01-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors
Sponsor:
MedImmune LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-02-22
Start Date Type:
ACTUAL
Primary Completion Date:
2021-10-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-09-01
Completion Date Type:
ESTIMATED
First Submit Date:
2016-01-28
First Submit QC Date:
None
Study First Post Date:
2016-02-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-10-21
Results First Submit QC Date:
None
Results First Post Date:
2023-03-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-18
Last Update Post Date:
2025-07-22
Last Update Post Date Type:
ACTUAL